Skip to main content

Amputation; Traumatic, Hand

0
Pipeline Programs
3
Companies
8
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Colorado Therapeutics
Colorado TherapeuticsCO - Louisville
6 programs
Point DigitN/A1 trial
Point DigitN/A1 trial
Point MiniN/A1 trial
Point PartialN/A1 trial
Point PartialN/A1 trial
+1 more programs
Active Trials
NCT04763278Completed7Est. Mar 2022
NCT04755790Completed13Est. Dec 2022
NCT06504667Withdrawn0Est. Jul 2025
+3 more trials
Human BioSciences
Human BioSciencesWV - Martinsburg
3 programs
Point DigitN/A
Point MiniN/A
Point MiniN/A1 trial
Active Trials
NCT06501092Recruiting14Est. Jul 2026
Martin Pharmaceuticals
1 program
FeetBack System ActiveN/A1 trial
Active Trials
NCT03924310Completed4Est. Nov 2021

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Colorado TherapeuticsPoint Powered partial hand prosthetic system
Colorado TherapeuticsPoint Mini
Human BioSciencesPoint Mini
Martin PharmaceuticalsFeetBack System Active
Colorado TherapeuticsPoint Digit
Colorado TherapeuticsPoint Partial
Colorado TherapeuticsPoint Partial
Colorado TherapeuticsPoint Digit

Clinical Trials (8)

Total enrollment: 64 patients across 8 trials

NCT07135947Colorado TherapeuticsPoint Powered partial hand prosthetic system

To Evaluate the Clinical Impact of the Point Powered System

Start: Nov 2025Est. completion: Aug 202610 patients
N/ANot Yet Recruiting

To Validate Point Mini User Needs

Start: Jul 2025Est. completion: Jul 20250
N/AWithdrawn

To Assess the Utility of the Point Mini in a Clinical Take-home Study

Start: Jun 2025Est. completion: Jul 202614 patients
N/ARecruiting
NCT03924310Martin PharmaceuticalsFeetBack System Active

Sensor Glove and Non-Invasive Vibrotactile Feedback Insole to Improve Hand Prostheses Functions and Embodiment

Start: Aug 2021Est. completion: Nov 20214 patients
N/ACompleted

Validation of User Needs of the Point Digit With Partial Hand Amputees

Start: Jan 2021Est. completion: Mar 20227 patients
N/ACompleted

To Assess the Utility of the Point Partial in a Clinical Take-home Study of Partial Hand Amputees

Start: Jan 2021Est. completion: Dec 202211 patients
N/ACompleted

Validation of Point Partial User Needs With Partial Finger Amputees

Start: Nov 2020Est. completion: Dec 20225 patients
N/ACompleted

To Assess the Utility of the Point Digit in a Clinical Take-home Study

Start: May 2020Est. completion: Dec 202213 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials targeting 64 patients
3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.